Evidence map›Paper›PMID 37176742›Full record

ArticleJournal of clinical medicine2023

Association of Renin-Angiotensin System Blockers with Survival in Patients on Maintenance Hemodialysis.

Seok Hui Kang, Bo Yeon Kim, Eun Jung Son, Gui Ok Kim, Jun Young Do

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Seok Hui KangDivision of Nephrology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.ORCID 0000-0003-1023-0195
Bo Yeon KimHealthcare Review and Assessment Committee, Health Insurance Review and Assessment Service, Wonju 26465, Republic of Korea.
Eun Jung SonQuality Assessment Department, Health Insurance Review and Assessment Service, Wonju 26465, Republic of Korea.
Gui Ok KimQuality Assessment Department, Health Insurance Review and Assessment Service, Wonju 26465, Republic of Korea.
Jun Young DoDivision of Nephrology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.ORCID 0000-0002-6360-9310

Funding

The Basic Science Research Program through the NRF of Korea, funded by the Ministry of Education 2022R1I1A3072966The Medical Research Center Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT, and Future Planning 2022R1A5A2018865The NRF grant funded by the Korea government (MSIT) 2022R1F1A1076151
6 · The paper itself

Abstract

Additional studies are needed to confirm whether the use of renin-angiotensin system blockers (RASBs) induces survival benefits in patients on hemodialysis (HD). This study aimed to evaluate patient survival with the use of RASBs in a large sample of maintenance HD patients. This study used data from the national HD quality assessment program and claim data from South Korea (

Indexed as

angiotensin-converting enzyme inhibitorangiotensin II receptor blockerhemodialysisrenin-angiotensin systemsurvival

Identifiers

PMID37176742
PMCPMC10179028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.